Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of ALEMBIC PHARMA. For more details, see the ALEMBIC PHARMA quarterly results and ALEMBIC PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -3.1 |
No. of shares | m | 196.56 |
1 Week | % | -6.9 |
1 Month | % | -1.4 |
1 Year | % | 76.2 |
52 week H/L | Rs | 1,093.1/516.6 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
ALEMBIC PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 664 | 683 | 1,150 | 1,090 | 792 | |
Low | Rs | 412 | 435 | 527 | 672 | 463 | |
Sales per share (Unadj.) | Rs | 208.7 | 244.3 | 274.4 | 269.9 | 287.6 | |
Earnings per share (Unadj.) | Rs | 31.4 | 42.5 | 56.7 | 26.5 | 17.4 | |
Diluted earnings per share | Rs | 30.1 | 40.7 | 56.7 | 26.5 | 17.4 | |
Cash flow per share (Unadj.) | Rs | 37.5 | 50.8 | 66.0 | 41.1 | 31.4 | |
Dividends per share (Unadj.) | Rs | 5.50 | 10.00 | 14.00 | 10.00 | 8.00 | |
Adj. dividends per share | Rs | 5.27 | 9.59 | 14.00 | 10.00 | 8.00 | |
Avg Dividend yield | % | 1.0 | 1.8 | 1.7 | 1.1 | 1.3 | |
Book value per share (Unadj.) | Rs | 144.2 | 170.8 | 257.8 | 266.5 | 222.3 | |
Adj. book value per share | Rs | 138.3 | 163.8 | 257.8 | 266.5 | 222.3 | |
Shares outstanding (eoy) | m | 188.52 | 188.52 | 196.56 | 196.56 | 196.56 | |
Price / Sales ratio | x | 2.6 | 2.3 | 3.1 | 3.3 | 2.2 | |
Avg P/E ratio | x | 17.1 | 13.2 | 14.8 | 33.2 | 36.1 | |
P/CF ratio (eoy) | x | 14.3 | 11.0 | 12.7 | 21.4 | 20.0 | |
Price / Book Value ratio | x | 3.7 | 3.3 | 3.3 | 3.3 | 2.8 | |
Dividend payout | % | 17.5 | 23.5 | 24.7 | 37.7 | 46.0 | |
Avg Mkt Cap | Rs m | 101,459 | 105,343 | 164,818 | 173,172 | 123,402 | |
Total wages/salary | Rs m | 7,467 | 9,064 | 10,512 | 11,330 | 11,691 |
ALEMBIC PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 39,347 | 46,058 | 53,931 | 53,058 | 56,526 | |
Other income | Rs m | 271 | 139 | 875 | 505 | 30 | |
Total revenues | Rs m | 39,618 | 46,196 | 54,806 | 53,563 | 56,557 | |
Gross profit | Rs m | 8,558 | 11,704 | 14,801 | 8,794 | 6,772 | |
Depreciation | Rs m | 1,152 | 1,573 | 1,835 | 2,868 | 2,754 | |
Interest | Rs m | 184 | 272 | 160 | 177 | 502 | |
Profit before tax | Rs m | 7,493 | 9,998 | 13,681 | 6,254 | 3,546 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 1,568 | 1,992 | 2,533 | 1,045 | 126 | |
Profit after tax | Rs m | 5,926 | 8,006 | 11,148 | 5,209 | 3,420 | |
Gross profit margin | % | 21.8 | 25.4 | 27.4 | 16.6 | 12.0 | |
Effective tax rate | % | 20.9 | 19.9 | 18.5 | 16.7 | 3.6 | |
Net profit margin | % | 15.1 | 17.4 | 20.7 | 9.8 | 6.1 |
ALEMBIC PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 21,317 | 26,654 | 29,044 | 29,748 | 29,139 | |
Current liabilities | Rs m | 16,637 | 19,542 | 15,333 | 18,306 | 16,408 | |
Net working cap to sales | % | 11.9 | 15.4 | 25.4 | 21.6 | 22.5 | |
Current ratio | x | 1.3 | 1.4 | 1.9 | 1.6 | 1.8 | |
Inventory Days | Days | 10 | 10 | 18 | 11 | 10 | |
Debtors Days | Days | 5 | 7 | 2 | 6 | 7 | |
Net fixed assets | Rs m | 28,200 | 35,263 | 40,570 | 42,554 | 31,498 | |
Share capital | Rs m | 377 | 377 | 393 | 393 | 393 | |
"Free" reserves | Rs m | 26,811 | 31,817 | 50,277 | 51,982 | 43,312 | |
Net worth | Rs m | 27,188 | 32,194 | 50,670 | 52,375 | 43,705 | |
Long term debt | Rs m | 4,993 | 8,870 | 1,999 | 0 | 0 | |
Total assets | Rs m | 49,518 | 61,917 | 69,614 | 72,302 | 60,637 | |
Interest coverage | x | 41.7 | 37.8 | 86.4 | 36.3 | 8.1 | |
Debt to equity ratio | x | 0.2 | 0.3 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.8 | 0.7 | 0.8 | 0.7 | 0.9 | |
Return on assets | % | 12.3 | 13.4 | 16.2 | 7.5 | 6.5 | |
Return on equity | % | 21.8 | 24.9 | 22.0 | 9.9 | 7.8 | |
Return on capital | % | 23.9 | 25.0 | 26.3 | 12.3 | 9.3 | |
Exports to sales | % | 49.4 | 47.3 | 66.8 | 43.8 | 46.4 | |
Imports to sales | % | 15.4 | 13.2 | 12.7 | 12.7 | 12.1 | |
Exports (fob) | Rs m | 19,453 | 21,808 | 36,020 | 23,251 | 26,210 | |
Imports (cif) | Rs m | 6,065 | 6,062 | 6,845 | 6,728 | 6,846 | |
Fx inflow | Rs m | 19,453 | 21,808 | 36,020 | 23,251 | 26,210 | |
Fx outflow | Rs m | 6,065 | 6,062 | 6,845 | 6,728 | 6,846 | |
Net fx | Rs m | 13,388 | 15,746 | 29,175 | 16,523 | 19,364 |
ALEMBIC PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 8,120 | 4,492 | 14,634 | 5,524 | 7,240 | |
From Investments | Rs m | -7,556 | -7,316 | -8,388 | -3,720 | -4,476 | |
From Financial Activity | Rs m | 590 | 1,549 | -5,974 | -2,174 | -2,620 | |
Net Cashflow | Rs m | 1,153 | -1,272 | 262 | -370 | 144 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Chirayu Amin | COMP SEC: Charandeep Singh Saluja | YEAR OF INC: 2010 | BSE CODE: 533573 | FV (Rs): 2 | DIV YIELD (%): 0.9 |
Read: ALEMBIC PHARMA 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare ALEMBIC PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.